Caty has spent 15 years in biotechnology, leading patient experience for companies with innovative health tech products, including the first-ever prescription digital therapeutic for cognitive impairment-related disorders, the first broad companion diagnostic genetic sequencing panel in oncology, and now the first and only direct-to-patient, AI-based genetic testing program for rare conditions (with Probably Genetic!). Caty is also actively involved with several nonprofit organizations, including serving as a member of the marketing committee for Breast Cancer Prevention Partners and supporting Cancer Support Community, where she can -- like bartending! Her why is simple: lovingly honoring her mom, Macy, and every patient fighting cancer.